Proactive machine-learning-based approaches to vaccine hesitancy for a potential SARS-Cov-2 vaccine

被引:0
|
作者
Oreskovic, T. [1 ]
TIljak, M. Kujundzic [2 ]
机构
[1] IBM Corp, IBM Sci Social Good, New York, NY USA
[2] Univ Zagreb, Sch Med, Andrija Stampar Sch Publ Hlth, Zagreb, Croatia
来源
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页码:V17 / V17
页数:1
相关论文
共 50 条
  • [41] Vaccine Hesitancy Against SARS-CoV-2 in Health Personnel of Northeastern Mexico and Its Determinants
    Castaneda-Vasquez, David Emmanuel
    Ruiz-Padilla, Juan Pablo
    Botello-Hernandez, Edgar
    JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2021, 63 (08) : 633 - 637
  • [42] A protective AAV vaccine for SARS-CoV-2
    Simeng Zhao
    Junzi Ke
    Boyu Yang
    Fangzhi Tan
    Jie Yang
    Chao-Po Lin
    Haopeng Wang
    Guisheng Zhong
    Signal Transduction and Targeted Therapy, 7
  • [43] SARS-CoV-2 incidence and vaccine escape
    Thompson, Robin N.
    Hill, Edward M.
    Gog, Julia R.
    LANCET INFECTIOUS DISEASES, 2021, 21 (07): : 913 - 914
  • [44] Impact of vaccine hesitancy on antibody response after SARS-CoV-2 vaccination in patients with cancere
    Overheu, Oliver
    Lendowski, Simon
    Quast, Daniel R.
    Kuehn, Daniel
    Blanco, Elena Vidal
    Lugnier, Celine
    Kraeft, Anna-Lena
    Steinmann, Eike
    Kourti, Eleni
    Steinmann, Joerg
    Pfaender, Stephanie
    Reinacher-Schick, Anke C.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [45] Immunophenotyping of SARS-CoV-2 and vaccine design
    Cimolai, Nevio
    VACCINE, 2022, 40 (30) : 3985 - 3986
  • [47] Modular nanoarray vaccine for SARS-CoV-2
    Zagorski, Karen
    Pandey, Kabita
    Rajaiah, Rajesh
    Olwenyi, Omalla A.
    Bade, Aditya N.
    Acharya, Arpan
    Johnston, Morgan
    Filliaux, Shaun
    Lyubchenko, Yuri L.
    Byrareddy, Siddappa N.
    Nanomedicine: Nanotechnology, Biology, and Medicine, 2022, 46
  • [48] Immunophenotyping of SARS-CoV-2 and vaccine design
    Cimolai, Nevio
    VACCINE, 2022, 40 (29) : 3985 - 3986
  • [49] Effectiveness of an Inactivated SARS-CoV-2 Vaccine
    Wilder-Smith, Annelies
    Mulholland, Kim
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (10): : 946 - 948
  • [50] Vaccine Strategies and Processes for Vaccine Development Against SARS-CoV-2
    Kunchev, M.
    Gergova, J.
    Mutafchiyski, V
    Titianov, E.
    NEUROSONOLOGY AND CEREBRAL HEMODYNAMICS, 2021, 17 (01): : 29 - 35